Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-4 of 4 for your search:
Drug:
granisetron hydrochloride
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors
Phase:
Phase IV
Type:
Supportive care, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
2006-00055-18
, NCT00415103
2.
Phase III Randomized Study of Different Combinations of Granisetron Hydrochloride, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron Hydrochloride in Preventing Delayed Nausea in Patients Undergoing Chemotherapy for Chemotherapy-Naive Breast Cancer
Phase:
Phase III
Type:
Supportive care
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
URCC-04-02
, URCC 0402, URCC-U1105, U1105, NCT00475085
3.
Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-Dose Chemotherapy
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
EmNa (2001-004956-38)
, EudraCT-No: 2004-004956-38, NCT00571168
4.
Pilot Study of Aprepitant, Granisetron Hydrochloride, and Dexamethasone in Patients With Nausea and Vomiting Due to Therapy Comprising High Dose Cyclophosphamide Prior to Autologous Peripheral Blood Stem Transplantation
Phase:
No phase specified
Type:
Supportive care, Treatment
Status:
Active
Age:
Over 18
Sponsor:
NCI
Protocol IDs:
WSU-D-2797
, WSU-0504001728, NCT00293384
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute